Efficacy and Safety of Eplerenone for Treating Chronic Kidney Disease: A Meta-Analysis

Figure 3

(a) Effect on 24-h proteinuria in articles comparing eplerenone to placebo/active control. (b) Effect on UACR for the eplerenone versus placebo/active control. The black diamond indicates summary information with the center of the estimate pooled with the median difference, and the width covers the relevant 95% CIs.

(a)

(b)